Scandinavian Medical Solutions A/S (CPH: SMSMED)

SMSMED Income Statement

Financials in millions DKK. Fiscal year is October - September.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Revenue	197.51	191.19	110.53	71.64	41.95
Revenue Growth (YoY)	27.60%	72.98%	54.29%	70.78%	-
Cost of Revenue	166.38	156.46	87.85	57.76	34.59
Gross Profit	31.14	34.73	22.68	13.88	7.36
Selling, General & Admin	16.44	13.65	7.33	2.98	1.37
Operating Expenses	22.6	18.1	7.94	3.01	1.39
Operating Income	8.54	16.63	14.74	10.87	5.96
Interest Expense	-1.69	-0.98	-0.25	-0.54	-0.28
Currency Exchange Gain (Loss)	0.14	0.14	0.22	0.2	0.13
Pretax Income	7	15.79	14.71	10.54	5.82
Income Tax Expense	1.63	3.57	3.34	2.38	1.31
Net Income	5.37	12.22	11.37	8.16	4.51
Net Income to Common	5.37	12.22	11.37	8.16	4.51
Net Income Growth	-67.06%	7.49%	39.42%	80.82%	-
Shares Outstanding (Basic)	27	27	27	-	-
Shares Outstanding (Diluted)	27	27	27	-	-
Shares Change (YoY)	0.39%	2.22%	-	-	-
EPS (Basic)	0.20	0.45	0.43	-	-
EPS (Diluted)	0.20	0.45	0.43	-	-
EPS Growth	-67.19%	5.16%	-	-	-
Free Cash Flow	-31.18	-49.19	-24.33	4.02	9.38
Free Cash Flow Per Share	-1.14	-1.80	-0.91	-	-
Gross Margin	15.77%	18.16%	20.52%	19.38%	17.53%
Operating Margin	4.32%	8.70%	13.34%	15.18%	14.22%
Profit Margin	2.72%	6.39%	10.29%	11.39%	10.75%
Free Cash Flow Margin	-15.79%	-25.73%	-22.01%	5.62%	22.36%
EBITDA	14.7	21.08	15.35	10.9	5.99
EBITDA Margin	7.44%	11.03%	13.89%	15.21%	14.28%
D&A For EBITDA	6.16	4.46	0.61	0.02	0.02
EBIT	8.54	16.63	14.74	10.87	5.96
EBIT Margin	4.32%	8.70%	13.34%	15.18%	14.22%
Effective Tax Rate	23.24%	22.60%	22.70%	22.61%	22.46%

Source: S&P Capital IQ. Standard template. Financial Sources.